Article
Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkers
2019-01-07
Abstract excerpt
Patient-derived models are transforming translational cancer research. It is not clear if the emergence of patient-derived organoid (PDO) models can extend the utility of the widely used patient-derived xenograft (PDX). In addition, the utility of PDO models for serum biomarker discovery is not known. Here, we demonstrate that PDO models recapitulate the genomics, cell biology, glycomics and drug responses observe...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 162efb81-1394-525d-a0bb-ff808fb99045
- DOI
- 10.1101/513267
